CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Wedbush Adjusts Price Target on Zentalis Pharmaceuticals to $5 From $4, Maintains Neutral Rating

Neutral
AI Analysis

Summary

Wedbush raised its price target on Zentalis Pharmaceuticals to $5 from $4 while maintaining a Neutral rating.

Importance:2/10
Sentiment:
0.00
analyst_ratingprice_targetequity_research
Related Companies

Read the original article

Published by yahoo_finance on August 7, 2026 1:42 PM

Read Original